End-stage renal disease following carboplatin chemotherapy for a nasopharyngeal carcinoma

4Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Renal failure secondary to carboplatin therapy is due to acute tubular necrosis and is usually reversible. However, acute renal failure with rapid progression to end-stage renal disease is an exceedingly rare complication of carboplatin therapy. The authors report a case of definitive renal failure secondary to carboplatin chemotherapy for a nasopharyngeal carcinoma. The mechanisms that give rise to the chronic nephropathy are discussed. Copyright © Informa Healthcare USA, Inc.

Cite

CITATION STYLE

APA

Tarrass, F., Benmensour, M., & Bayla, A. (2007). End-stage renal disease following carboplatin chemotherapy for a nasopharyngeal carcinoma. Renal Failure, 29(8), 1049–1051. https://doi.org/10.1080/08860220701643591

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free